Company / SG&A per Share
ARDELYX, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.38
FY2025
5-year range
$0.58 / $1.38
FY2021-FY2025
Trend
+27.0%
vs FY2024
Sector context
#103 of 210
Health Care
What the data says
At $1.38, ARDELYX, INC.'s sg&a per share ranks #108 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $0.28 in FY2016 to $1.38 in FY2025.
Based on SEC 10-K filings.
1.38 in FY2025 with a 5-year CAGR of +29.9%.
Increased from $0.58 to $1.38 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +32.9%
- 5-Year CAGR
- +29.9%
- 10-Year CAGR
- -
Sector benchmark
#108 of 210 in Health CareTop 51% of 210This company $1.38 Sector average $40.75
▼
-96.6% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 27.0% year-over-year.
- Ranks #103 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.38 | +27.0% |
| FY2024 | $1.09 | +88.0% |
| FY2023 | $0.58 | -1.7% |
| FY2022 | $0.59 | -23.8% |
| FY2021 | $0.77 | +106.9% |
| FY2020 | $0.37 | -3.8% |
| FY2019 | $0.39 | -22.2% |
| FY2018 | $0.50 | +74.4% |
| FY2017 | $0.29 | +1.9% |
| FY2016 | $0.28 | -61.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026